Cargando…

Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis

INTRODUCTION: Tobacco use is associated with insulin resistance and incident diabetes. Given the racial/ethnic differences in smoking patterns and incident type 2 diabetes our objective was to evaluate the association between tobacco use and insulin resistance (IR) as well as incident type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Keith, Rachel J., Al Rifai, Mahmoud, Carruba, Christopher, De Jarnett, Natasha, McEvoy, John W., Bhatnagar, Aruni, Blaha, Michael J., Defilippis, Andrew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913922/
https://www.ncbi.nlm.nih.gov/pubmed/27322410
http://dx.doi.org/10.1371/journal.pone.0157592
_version_ 1782438477211631616
author Keith, Rachel J.
Al Rifai, Mahmoud
Carruba, Christopher
De Jarnett, Natasha
McEvoy, John W.
Bhatnagar, Aruni
Blaha, Michael J.
Defilippis, Andrew P.
author_facet Keith, Rachel J.
Al Rifai, Mahmoud
Carruba, Christopher
De Jarnett, Natasha
McEvoy, John W.
Bhatnagar, Aruni
Blaha, Michael J.
Defilippis, Andrew P.
author_sort Keith, Rachel J.
collection PubMed
description INTRODUCTION: Tobacco use is associated with insulin resistance and incident diabetes. Given the racial/ethnic differences in smoking patterns and incident type 2 diabetes our objective was to evaluate the association between tobacco use and insulin resistance (IR) as well as incident type 2 diabetes mellitus in a contemporary multiethnic cohort. METHODS AND RESULTS: We studied 5,931 Multi- Ethnic Study of Atherosclerosis (MESA) participants who at baseline were free of type 2 diabetes (fasting glucose ≥7.0 mmol/l (126 mg/dl) and/or use of insulin or oral hypoglycemic medications) categorized by self-reported tobacco status and reclassified by urinary cotinine (available in 58% of participants) as never, current or former tobacco users. The association between tobacco use, IR (fasting plasma glucose, insulin, and the homeostatic model assessment of insulin resistance (HOMA-IR)) and incident diabetes over 10 years was evaluated using multivariable linear regression and Cox proportional hazards models, respectively. Mean age of the participants was 62 (±10) years, 46% were male, 41% Caucasian, 12% Chinese, 26% African American and 21% Hispanic/Latino. IR biomarkers did not significantly differ between current, former, and never cigarette users (P >0.10) but showed limited unadjusted differences for users of cigar, pipe and smokeless tobacco (All P <0.05). Fully adjusted models showed no association between dose or intensity of tobacco exposure and any index of IR. When stratified into participants that quit smoking vs. those who continued smoking during the 10-year study there was no difference in serum glucose levels or frequency of diabetes. In fully adjusted models, there was no significant difference in diabetes risk between former or current cigarette smokers compared to never smokers [HR (95% CI) 1.02 (0.77,1.37) and 0.81 (0.52,1.26) respectively]. CONCLUSION: In a contemporary multi-ethnic cohort, there was no independent association between tobacco use and IR or incident type 2 diabetes. The role smoking plays in causing diabetes may be more complicated than originally thought and warrants more in-depth large contemporary multi-ethnic studies.
format Online
Article
Text
id pubmed-4913922
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49139222016-07-06 Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis Keith, Rachel J. Al Rifai, Mahmoud Carruba, Christopher De Jarnett, Natasha McEvoy, John W. Bhatnagar, Aruni Blaha, Michael J. Defilippis, Andrew P. PLoS One Research Article INTRODUCTION: Tobacco use is associated with insulin resistance and incident diabetes. Given the racial/ethnic differences in smoking patterns and incident type 2 diabetes our objective was to evaluate the association between tobacco use and insulin resistance (IR) as well as incident type 2 diabetes mellitus in a contemporary multiethnic cohort. METHODS AND RESULTS: We studied 5,931 Multi- Ethnic Study of Atherosclerosis (MESA) participants who at baseline were free of type 2 diabetes (fasting glucose ≥7.0 mmol/l (126 mg/dl) and/or use of insulin or oral hypoglycemic medications) categorized by self-reported tobacco status and reclassified by urinary cotinine (available in 58% of participants) as never, current or former tobacco users. The association between tobacco use, IR (fasting plasma glucose, insulin, and the homeostatic model assessment of insulin resistance (HOMA-IR)) and incident diabetes over 10 years was evaluated using multivariable linear regression and Cox proportional hazards models, respectively. Mean age of the participants was 62 (±10) years, 46% were male, 41% Caucasian, 12% Chinese, 26% African American and 21% Hispanic/Latino. IR biomarkers did not significantly differ between current, former, and never cigarette users (P >0.10) but showed limited unadjusted differences for users of cigar, pipe and smokeless tobacco (All P <0.05). Fully adjusted models showed no association between dose or intensity of tobacco exposure and any index of IR. When stratified into participants that quit smoking vs. those who continued smoking during the 10-year study there was no difference in serum glucose levels or frequency of diabetes. In fully adjusted models, there was no significant difference in diabetes risk between former or current cigarette smokers compared to never smokers [HR (95% CI) 1.02 (0.77,1.37) and 0.81 (0.52,1.26) respectively]. CONCLUSION: In a contemporary multi-ethnic cohort, there was no independent association between tobacco use and IR or incident type 2 diabetes. The role smoking plays in causing diabetes may be more complicated than originally thought and warrants more in-depth large contemporary multi-ethnic studies. Public Library of Science 2016-06-20 /pmc/articles/PMC4913922/ /pubmed/27322410 http://dx.doi.org/10.1371/journal.pone.0157592 Text en © 2016 Keith et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Keith, Rachel J.
Al Rifai, Mahmoud
Carruba, Christopher
De Jarnett, Natasha
McEvoy, John W.
Bhatnagar, Aruni
Blaha, Michael J.
Defilippis, Andrew P.
Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis
title Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis
title_full Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis
title_fullStr Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis
title_full_unstemmed Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis
title_short Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis
title_sort tobacco use, insulin resistance, and risk of type 2 diabetes: results from the multi-ethnic study of atherosclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913922/
https://www.ncbi.nlm.nih.gov/pubmed/27322410
http://dx.doi.org/10.1371/journal.pone.0157592
work_keys_str_mv AT keithrachelj tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT alrifaimahmoud tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT carrubachristopher tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT dejarnettnatasha tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT mcevoyjohnw tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT bhatnagararuni tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT blahamichaelj tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis
AT defilippisandrewp tobaccouseinsulinresistanceandriskoftype2diabetesresultsfromthemultiethnicstudyofatherosclerosis